DHR250117P250000
- 12.90
- +2.18+20.34%
Danaher Newsroom
BofA Securities Maintains Danaher(DHR.US) With Buy Rating, Maintains Target Price $290
TD Cowen Maintains Danaher(DHR.US) With Buy Rating, Maintains Target Price $315
BofA Securities Maintains Danaher(DHR.US) With Buy Rating, Maintains Target Price $290
Barclays Maintains Danaher(DHR.US) With Hold Rating, Maintains Target Price $275
Danaher Analyst Ratings
Wolfe Research Adjusts Danaher's Price Target to $275 From $285, Keeps Outperform Rating
Citi Maintains Danaher(DHR.US) With Buy Rating, Maintains Target Price $285
Danaher (DHR) Receives a Buy From Citi
Evercore Maintains Danaher(DHR.US) With Buy Rating, Cuts Target Price to $268
Danaher Initiated at Sector Perform by Scotiabank
Scotiabank Initiates Danaher(DHR.US) With Hold Rating, Announces Target Price $265
Guggenheim Initiates Danaher(DHR.US) With Buy Rating, Announces Target Price $275
Guggenheim Initiates Danaher at Buy With $275 Price Target
Deutsche Bank Adjusts Danaher Price Target to $270 From $275
Danaher Raised to Buy From Neutral by B of A Securities
Danaher Analyst Ratings
Jefferies Maintains Danaher(DHR.US) With Buy Rating, Cuts Target Price to $285
BofA Securities Upgrades Danaher(DHR.US) to Buy Rating, Maintains Target Price $290
RBC Trims Price Target on Danaher to $308 From $311, Keeps Outperform Rating
Wolfe Research Maintains Danaher(DHR.US) With Buy Rating, Maintains Target Price $285